WO2004058385A1 - Melt-spun polysulfone semipermeable membranes and methods for making the same - Google Patents
Melt-spun polysulfone semipermeable membranes and methods for making the same Download PDFInfo
- Publication number
- WO2004058385A1 WO2004058385A1 PCT/US2003/040499 US0340499W WO2004058385A1 WO 2004058385 A1 WO2004058385 A1 WO 2004058385A1 US 0340499 W US0340499 W US 0340499W WO 2004058385 A1 WO2004058385 A1 WO 2004058385A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polysulfone
- acid
- ester
- semipermeable membrane
- methyl
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 178
- 229920002492 poly(sulfone) Polymers 0.000 title claims abstract description 165
- 238000000034 method Methods 0.000 title claims abstract description 64
- 239000002904 solvent Substances 0.000 claims abstract description 117
- 239000000203 mixture Substances 0.000 claims abstract description 104
- 150000001875 compounds Chemical class 0.000 claims abstract description 65
- 239000007788 liquid Substances 0.000 claims abstract description 53
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 14
- 238000000926 separation method Methods 0.000 claims abstract description 12
- 238000002074 melt spinning Methods 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 156
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 72
- -1 poly(ethylene glycol) Polymers 0.000 claims description 66
- 235000011187 glycerol Nutrition 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 claims description 29
- 229920001223 polyethylene glycol Polymers 0.000 claims description 25
- 230000008569 process Effects 0.000 claims description 25
- 238000010791 quenching Methods 0.000 claims description 20
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 19
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims description 15
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 14
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 14
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 13
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 12
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 claims description 10
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 claims description 10
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 claims description 10
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical compound COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 claims description 10
- JVZRCNQLWOELDU-UHFFFAOYSA-N 4-Phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=NC=C1 JVZRCNQLWOELDU-UHFFFAOYSA-N 0.000 claims description 10
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 claims description 10
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims description 10
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 10
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 claims description 10
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 claims description 10
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 10
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 10
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 10
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 claims description 10
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 10
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 claims description 10
- LJOODBDWMQKMFB-UHFFFAOYSA-N cyclohexylacetic acid Chemical compound OC(=O)CC1CCCCC1 LJOODBDWMQKMFB-UHFFFAOYSA-N 0.000 claims description 10
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 claims description 10
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 claims description 10
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 claims description 10
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 10
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 claims description 10
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 claims description 10
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 claims description 10
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 10
- GPSDUZXPYCFOSQ-UHFFFAOYSA-N m-toluic acid Chemical compound CC1=CC=CC(C(O)=O)=C1 GPSDUZXPYCFOSQ-UHFFFAOYSA-N 0.000 claims description 10
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 claims description 10
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 claims description 10
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 10
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 10
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 10
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 10
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 claims description 9
- QQLIGMASAVJVON-UHFFFAOYSA-N 1-naphthalen-1-ylethanone Chemical compound C1=CC=C2C(C(=O)C)=CC=CC2=C1 QQLIGMASAVJVON-UHFFFAOYSA-N 0.000 claims description 8
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 claims description 8
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 claims description 8
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 8
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 7
- 229920013655 poly(bisphenol-A sulfone) Polymers 0.000 claims description 7
- 230000000171 quenching effect Effects 0.000 claims description 7
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 6
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 claims description 6
- XLJMAIOERFSOGZ-UHFFFAOYSA-N anhydrous cyanic acid Natural products OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 claims description 6
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 claims description 6
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 6
- 229960005222 phenazone Drugs 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- TUMNHQRORINJKE-UHFFFAOYSA-N 1,1-diethylurea Chemical compound CCN(CC)C(N)=O TUMNHQRORINJKE-UHFFFAOYSA-N 0.000 claims description 5
- IZUKQUVSCNEFMJ-UHFFFAOYSA-N 1,2-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1[N+]([O-])=O IZUKQUVSCNEFMJ-UHFFFAOYSA-N 0.000 claims description 5
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 claims description 5
- ZWAVGZYKJNOTPX-UHFFFAOYSA-N 1,3-diethylurea Chemical compound CCNC(=O)NCC ZWAVGZYKJNOTPX-UHFFFAOYSA-N 0.000 claims description 5
- SUGXZLKUDLDTKX-UHFFFAOYSA-N 1-(2-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1[N+]([O-])=O SUGXZLKUDLDTKX-UHFFFAOYSA-N 0.000 claims description 5
- GPRYKVSEZCQIHD-UHFFFAOYSA-N 1-(4-aminophenyl)ethanone Chemical compound CC(=O)C1=CC=C(N)C=C1 GPRYKVSEZCQIHD-UHFFFAOYSA-N 0.000 claims description 5
- OEZXLKSZOAWNJU-UHFFFAOYSA-N 1-isothiocyanato-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(N=C=S)=C1 OEZXLKSZOAWNJU-UHFFFAOYSA-N 0.000 claims description 5
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 claims description 5
- DYSXLQBUUOPLBB-UHFFFAOYSA-N 2,3-dinitrotoluene Chemical compound CC1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O DYSXLQBUUOPLBB-UHFFFAOYSA-N 0.000 claims description 5
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 claims description 5
- GZMAAYIALGURDQ-UHFFFAOYSA-N 2-(2-hexoxyethoxy)ethanol Chemical compound CCCCCCOCCOCCO GZMAAYIALGURDQ-UHFFFAOYSA-N 0.000 claims description 5
- AUWDOZOUJWEPBA-UHFFFAOYSA-N 2-(4-methoxyphenyl)ethanol Chemical compound COC1=CC=C(CCO)C=C1 AUWDOZOUJWEPBA-UHFFFAOYSA-N 0.000 claims description 5
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 claims description 5
- NBYLBWHHTUWMER-UHFFFAOYSA-N 2-Methylquinolin-8-ol Chemical compound C1=CC=C(O)C2=NC(C)=CC=C21 NBYLBWHHTUWMER-UHFFFAOYSA-N 0.000 claims description 5
- RFCQDOVPMUSZMN-UHFFFAOYSA-N 2-Naphthalenethiol Chemical compound C1=CC=CC2=CC(S)=CC=C21 RFCQDOVPMUSZMN-UHFFFAOYSA-N 0.000 claims description 5
- LAXBNTIAOJWAOP-UHFFFAOYSA-N 2-chlorobiphenyl Chemical group ClC1=CC=CC=C1C1=CC=CC=C1 LAXBNTIAOJWAOP-UHFFFAOYSA-N 0.000 claims description 5
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 5
- BHNHHSOHWZKFOX-UHFFFAOYSA-N 2-methyl-1H-indole Chemical compound C1=CC=C2NC(C)=CC2=C1 BHNHHSOHWZKFOX-UHFFFAOYSA-N 0.000 claims description 5
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 claims description 5
- CFBYEGUGFPZCNF-UHFFFAOYSA-N 2-nitroanisole Chemical compound COC1=CC=CC=C1[N+]([O-])=O CFBYEGUGFPZCNF-UHFFFAOYSA-N 0.000 claims description 5
- FAYFWMOSHFCQPG-UHFFFAOYSA-N 3-Methyl sulfolene Chemical compound CC1=CCS(=O)(=O)C1 FAYFWMOSHFCQPG-UHFFFAOYSA-N 0.000 claims description 5
- CMJLMPKFQPJDKP-UHFFFAOYSA-N 3-methylthiolane 1,1-dioxide Chemical compound CC1CCS(=O)(=O)C1 CMJLMPKFQPJDKP-UHFFFAOYSA-N 0.000 claims description 5
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 claims description 5
- BAJQRLZAPXASRD-UHFFFAOYSA-N 4-Nitrobiphenyl Chemical group C1=CC([N+](=O)[O-])=CC=C1C1=CC=CC=C1 BAJQRLZAPXASRD-UHFFFAOYSA-N 0.000 claims description 5
- DGRGLKZMKWPMOH-UHFFFAOYSA-N 4-methylbenzene-1,2-diamine Chemical compound CC1=CC=C(N)C(N)=C1 DGRGLKZMKWPMOH-UHFFFAOYSA-N 0.000 claims description 5
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 5
- IRIAEXORFWYRCZ-UHFFFAOYSA-N Butylbenzyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IRIAEXORFWYRCZ-UHFFFAOYSA-N 0.000 claims description 5
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 5
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 claims description 5
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 claims description 5
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 claims description 5
- JJHHIJFTHRNPIK-UHFFFAOYSA-N Diphenyl sulfoxide Chemical compound C=1C=CC=CC=1S(=O)C1=CC=CC=C1 JJHHIJFTHRNPIK-UHFFFAOYSA-N 0.000 claims description 5
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 5
- 239000004348 Glyceryl diacetate Substances 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 claims description 5
- 235000021355 Stearic acid Nutrition 0.000 claims description 5
- 229960001413 acetanilide Drugs 0.000 claims description 5
- BTGRAWJCKBQKAO-UHFFFAOYSA-N adiponitrile Chemical compound N#CCCCCC#N BTGRAWJCKBQKAO-UHFFFAOYSA-N 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- RPJGYLSSECYURW-UHFFFAOYSA-K antimony(3+);tribromide Chemical compound Br[Sb](Br)Br RPJGYLSSECYURW-UHFFFAOYSA-K 0.000 claims description 5
- 235000010233 benzoic acid Nutrition 0.000 claims description 5
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 5
- 239000012965 benzophenone Substances 0.000 claims description 5
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical compound C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 claims description 5
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 5
- OSXYHAQZDCICNX-UHFFFAOYSA-N dichloro(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](Cl)(Cl)C1=CC=CC=C1 OSXYHAQZDCICNX-UHFFFAOYSA-N 0.000 claims description 5
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 claims description 5
- LTYMSROWYAPPGB-UHFFFAOYSA-N diphenyl sulfide Chemical compound C=1C=CC=CC=1SC1=CC=CC=C1 LTYMSROWYAPPGB-UHFFFAOYSA-N 0.000 claims description 5
- YHHKGKCOLGRKKB-UHFFFAOYSA-N diphenylchlorarsine Chemical compound C=1C=CC=CC=1[As](Cl)C1=CC=CC=C1 YHHKGKCOLGRKKB-UHFFFAOYSA-N 0.000 claims description 5
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 claims description 5
- NJVOZLGKTAPUTQ-UHFFFAOYSA-M fentin chloride Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 NJVOZLGKTAPUTQ-UHFFFAOYSA-M 0.000 claims description 5
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims description 5
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 claims description 5
- 235000019443 glyceryl diacetate Nutrition 0.000 claims description 5
- 239000001087 glyceryl triacetate Substances 0.000 claims description 5
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 5
- SXCBDZAEHILGLM-UHFFFAOYSA-N heptane-1,7-diol Chemical compound OCCCCCCCO SXCBDZAEHILGLM-UHFFFAOYSA-N 0.000 claims description 5
- 229940040102 levulinic acid Drugs 0.000 claims description 5
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 5
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 claims description 5
- 229940073769 methyl oleate Drugs 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 239000012184 mineral wax Substances 0.000 claims description 5
- UNFUYWDGSFDHCW-UHFFFAOYSA-N monochlorocyclohexane Chemical compound ClC1CCCCC1 UNFUYWDGSFDHCW-UHFFFAOYSA-N 0.000 claims description 5
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 claims description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 5
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 claims description 5
- 239000012188 paraffin wax Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- JQMVGTOAKFLMOU-UHFFFAOYSA-N pentaoxane Chemical compound C1OOOOO1 JQMVGTOAKFLMOU-UHFFFAOYSA-N 0.000 claims description 5
- VTXLTXPNXYLCQD-UHFFFAOYSA-N phenoxymethoxybenzene Chemical compound C=1C=CC=CC=1OCOC1=CC=CC=C1 VTXLTXPNXYLCQD-UHFFFAOYSA-N 0.000 claims description 5
- NFGGQMYSOLVBLF-UHFFFAOYSA-N phenyl(1h-pyrrol-2-yl)methanone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CN1 NFGGQMYSOLVBLF-UHFFFAOYSA-N 0.000 claims description 5
- SKFLCXNDKRUHTA-UHFFFAOYSA-N phenyl(pyridin-4-yl)methanone Chemical compound C=1C=NC=CC=1C(=O)C1=CC=CC=C1 SKFLCXNDKRUHTA-UHFFFAOYSA-N 0.000 claims description 5
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical group C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 claims description 5
- 150000003071 polychlorinated biphenyls Chemical group 0.000 claims description 5
- RHWSKVCZXBAWLZ-OCAPTIKFSA-N pseudopelletierine Chemical compound C1CC[C@@H]2CC(=O)C[C@H]1N2C RHWSKVCZXBAWLZ-OCAPTIKFSA-N 0.000 claims description 5
- 239000008117 stearic acid Substances 0.000 claims description 5
- 239000003760 tallow Substances 0.000 claims description 5
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 claims description 5
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 claims description 5
- 229960002622 triacetin Drugs 0.000 claims description 5
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 claims description 5
- BIBZKNXZTAKPDB-UHFFFAOYSA-N trichloro-(2,3-dichlorophenyl)silane Chemical compound ClC1=CC=CC([Si](Cl)(Cl)Cl)=C1Cl BIBZKNXZTAKPDB-UHFFFAOYSA-N 0.000 claims description 5
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 claims description 5
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 claims description 5
- 229960004418 trolamine Drugs 0.000 claims description 5
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 claims description 5
- DLKQHBOKULLWDQ-UHFFFAOYSA-N 1-bromonaphthalene Chemical compound C1=CC=C2C(Br)=CC=CC2=C1 DLKQHBOKULLWDQ-UHFFFAOYSA-N 0.000 claims description 4
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 4
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 claims description 4
- 229930188620 butyrolactone Natural products 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 3
- 229960001047 methyl salicylate Drugs 0.000 claims description 3
- JTPNRXUCIXHOKM-UHFFFAOYSA-N 1-chloronaphthalene Chemical compound C1=CC=C2C(Cl)=CC=CC2=C1 JTPNRXUCIXHOKM-UHFFFAOYSA-N 0.000 claims description 2
- 239000003570 air Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000005453 pelletization Methods 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 6
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 6
- VHVOLFRBFDOUSH-NSCUHMNNSA-N Isosafrole Chemical compound C\C=C\C1=CC=C2OCOC2=C1 VHVOLFRBFDOUSH-NSCUHMNNSA-N 0.000 claims 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims 3
- 229930192474 thiophene Natural products 0.000 claims 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 238000005191 phase separation Methods 0.000 claims 2
- 229920000570 polyether Polymers 0.000 claims 2
- 229920006389 polyphenyl polymer Polymers 0.000 claims 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical compound OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 1
- 238000000108 ultra-filtration Methods 0.000 abstract description 15
- 238000000502 dialysis Methods 0.000 abstract description 13
- 238000001223 reverse osmosis Methods 0.000 abstract description 7
- 238000001471 micro-filtration Methods 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 3
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 239000000835 fiber Substances 0.000 description 110
- 239000012510 hollow fiber Substances 0.000 description 96
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 238000001125 extrusion Methods 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 238000000338 in vitro Methods 0.000 description 15
- 230000035699 permeability Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000000155 melt Substances 0.000 description 9
- 238000009987 spinning Methods 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 230000004907 flux Effects 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XSAYZAUNJMRRIR-UHFFFAOYSA-N 2-acetylnaphthalene Chemical compound C1=CC=CC2=CC(C(=O)C)=CC=C21 XSAYZAUNJMRRIR-UHFFFAOYSA-N 0.000 description 1
- 241000212376 Ammi Species 0.000 description 1
- 235000007034 Carum copticum Nutrition 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 229920000491 Polyphenylsulfone Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920003082 Povidone K 90 Polymers 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical group 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 150000002170 ethers Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920001427 mPEG Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001453 nonthrombogenic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000013166 platelet test Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- KAVSMINTEBGDTI-UHFFFAOYSA-N pyridine;thiophene Chemical compound C=1C=CSC=1.C1=CC=NC=C1 KAVSMINTEBGDTI-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/66—Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
- B01D71/68—Polysulfones; Polyethersulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/002—Organic membrane manufacture from melts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0023—Organic membrane manufacture by inducing porosity into non porous precursor membranes
- B01D67/0025—Organic membrane manufacture by inducing porosity into non porous precursor membranes by mechanical treatment, e.g. pore-stretching
- B01D67/0027—Organic membrane manufacture by inducing porosity into non porous precursor membranes by mechanical treatment, e.g. pore-stretching by stretching
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0023—Organic membrane manufacture by inducing porosity into non porous precursor membranes
- B01D67/003—Organic membrane manufacture by inducing porosity into non porous precursor membranes by selective elimination of components, e.g. by leaching
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
- B01D69/087—Details relating to the spinning process
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/09—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in organic liquids
- C08J3/091—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in organic liquids characterised by the chemical constitution of the organic liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/34—Molecular weight or degree of polymerisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/36—Hydrophilic membranes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2381/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen, or carbon only; Polysulfones; Derivatives of such polymers
- C08J2381/06—Polysulfones; Polyethersulfones
Definitions
- the present invention concerns polysulfone semipermeable membranes and methods for making the same.
- Contemporary semipermeable membranes are available in a variety of forms such as sheets, tubes, and hollow fibers.
- a "hollow fiber” is generally a hollow cylindrical structure in which the wall functions as a permeable, non-permeable, or semipermeable (i.e., selectively permeable) membrane depending upon the application.
- hollow fibers are used as cylindrical membranes that permit selective exchange of materials across the walls.
- Liquid-separation processes utilizing membranes having selective permeabilities require a variety of materials adapted for diversified applications.
- semipermeable membranes are currently favored for use in extracorporeal blood treatments including hemodialysis, hemofiltration, and hemodiafiltration.
- the membranes typically comprise hollow fibers bundled together and assembled in a casing in a manner allowing blood to flow simultaneously in a parallel manner through the lumina of the fibers while a blood-cleansing liquid is simultaneously passed through the casing so as to bathe the exterior surfaces of the hollow fibers with the liquid.
- Polymers utilized for selectively permeable membranes have included polymers, such as cellulose, cellulose acetate, polyamide, polyacrylonitrile, polyvinylalcohol, polymethyl methacrylate, polysulfone, polyolefin, or the like, depending upon the use of the membranes.
- Polysulfone compounds are of particular interest as they have, inter alia, excellent physical and chemical properties, such as resistance to heat, resistance to acids, resistance to alkali, and resistance to oxidation.
- Polysulfone compounds have been found to be biocompatible, capable of forming excellent pores and interstitia, and chemically inert to such compounds as bleach, disinfectants, and salt solutions.
- Polysulfone compounds can be sterilized by a number of methods, such as ethylene oxide (EtO), gamma irradiation, steam autoclave, and heated citric acid. Additionally, polysulfone compounds possess sufficient strength and resistance to wear to withstand repeated use and sterilization cycles. Conventionally, polysulfone hollow fibers have been formed by solution- spinning techniques. Producing polysulfone hollow fibers by solution-spinning techniques typically involves dissolving a polysulfone compound in a relatively large amount of an aprotic solvent and a non-solvent, then extruding the solution through a spinneret.
- a “solvent” is a compound in which the polysulfone compound substantially dissolves at the membrane-fabrication temperature (i.e., ambient temperature).
- a “non-solvent” is a compound in which the polysulfone compound is substantially insoluble at the membrane-fabrication temperature.
- the solvents must be sufficient to substantially dissolve the polysulfone compound and produce a homogeneous liquid at ambient temperature (membrane fabrication temperature).
- the solvents and non-solvents utilized for solution-spinning techniques require that the membranes be extensively leached and rinsed after fabrication, as even residual amounts left in the membranes can cause unacceptable contamination of fluids treated using the membranes. Avoiding such contamination is particularly important in membranes used for the treatment of blood by dialysis or the desalination of water by reverse osmosis.
- removal of the core liquid used to form the fiber lumen is especially difficult.
- a nonvolatile, water-soluble compound must then be added to preserve the membrane pore structure prior to drying the membrane.
- the non- volatile material also serves as a surfactant for later rewetting of the membranes.
- a non-homogeneous membrane has a dense skin or micro-porous barrier layer on one (or both) of the major surfaces of the membrane.
- the dense skin or micro-porous barrier layer comprises a relatively small portion of the membrane but contributes a disproportionally large amount of control on the permeability characteristics of the membrane.
- the present invention provides, inter alia, a novel method and polysulfone composition for preparing a homogeneous, semipermeable polysulfone membrane by melt-spinning.
- the polysulfone composition comprises a liquid mixture of an ultra-high-molecular-weight (UHMW) hydrophilic polymer such as polyvinylpyrrolidone, a polysulfone compound, a solvent, and a non-solvent that are relatively non-toxic and that preferably do not deleteriously affect the environment.
- UHMW ultra-high-molecular-weight
- the solvent may be selected from the group consisting of tetramethylene sulfone
- sulfolane 3-methyl sulfolane; benzophenone; n,n-dimethylacetamide; 2- pyrrolidone; 3-methylsulfolene; pyridine; thiopene; o-dichlorobenzene; 1- chloronaphthalene; methyl salicylate; anisole; o-nitroanisole; diphenyl ether; diphenoxy methane; acetophenone; p-methoxyphenyl-2-ethanol; 2-piperidine; antipyrine; diethyl phthalate; diphenyl sulfone; diphenyl sulfoxide; phthalic acid, dioctyl ester; phthalic acid, dimethyl ester; phthalic acid, diethyl ester; phthalic acid, dibutyl ester; phthalic acid, bis(2-ethylhexyl) ester; phthalic acid, benzyl butyl ester; and phenyl sul
- the non-solvent may be selected from the group consisting of poly(ethylene glycol), di(ethylene glycol), tri(ethylene glycol), glycerol, 1,1-diethylurea; 1,3- diethylurea; dinitrotoluene; 1,2-ethane diamine; diphenylamine; toluenediamine; o- toluic acid; m-toluic acid; toluene-3,4-diamine; dibutyl phthalate; piperidine; decalin; cyclohexane; cyclohexene; chlorocyclohexane; "cellosolve” solvent; n,n- dimethylbenzylamine; paraffin; mineral oil; mineral wax; tallow amine; triethanol amine; lauryl methacrylate; stearic acid; ethylene glycol; tetra(ethylene glycol); diethyl adipate; d-sorbitol; chlorotriphenyl stannane;
- the solvent and non-solvent are present in a ratio useful to form a semipermeable, polysulfone membrane useful for performing liquid-separation processes.
- a “melt-spinning” or “melt- extrusion” method for producing semipermeable, polysulfone membranes.
- the melt-spinning method includes the steps of: (1) forming a composition comprising a UHMW hydrophilic polymer, preferably, polyvinylpyrrohdone, a polysulfone compound, a solvent selected from the foregoing group of candidate solvents, and, a non-solvent selected from the foregoing group of candidate non-solvents; (2) heating the composition to a temperature at which the composition becomes a homogeneous liquid (i.e., a temperature greater than ambient); (3) extruding the composition through an extrusion die (such as a single or multi-holed hollow-fiber die (termed a "spinneret”); and (4) passing the extrudate through a quench zone in which the extrudate gels and solidifies, thereby forming the membrane.
- a UHMW hydrophilic polymer preferably, polyviny
- melt-spun, semipermeable, polysulfone membranes having a uniform structure throughout the thickness dimension of the membrane (i.e., a "homogeneous" membrane structure) useful for liquid separations, such as, but not limited to, microfiltration, ultrafiltration, reverse osmosis, and dialysis.
- Fig. 1 illustrates a preferred embodiment of the process for fabricating homogeneous polysulfone hollow fibers (as a representative membrane configuration).
- Fig. 2 illustrates an alternative process for fabricating homogeneous polysulfone hollow fibers.
- Fig. 3 is a three-component diagram showing the proportions of polysulfone compound, solvent, and non-solvent which are combined in representative melt-spin compositions.
- Fig. 4 is a scanning electron microscope photograph of a representative homogeneous, polysulfone hollow fiber.
- Fig. 5 is a schematic diagram of a hemodialyzer including homogeneous polysulfone hollow-fiber membranes.
- Fig. 6 illustrates a scanning electron microscope photograph of a cross-section of a representative polysulfone hollow-fiber membrane including ultra-high-molecular- weight hydrophillic polymer.
- Fig. 7 illustrates a scanning electron microscope photograph of a cross-section of a portion of a fiber wall of the representative polysulfone hollow-fiber membrane of Fig. 6 including ultra-high-molecular- weight hydrophillic polymer.
- Fig. 8 illustrates schematically an in-vitro platelet test system discussed in Example No. 8.
- Fig. 9 illustrates in-vitro anti-thrombogenic evaluation using bovine blood of Example No. 9.
- compositions useful for forming, by melt-spinning, polysulfone semipermeable membranes comprise a ultra-high-molecular-weight hydrophillic polymer, preferably polyvinylpyrrolidone
- melt-spun membranes are symmetric such that the membranes have a substantially uniform structure throughout the thickness dimension of the membranes, as illustrated in the scanning electron microscope photographs of Figs. 6 and 7 of a hollow fiber made using such compositions.
- a "homogeneous" polysulfone membrane is a membrane in which each portion or section of the membrane contributes its substantially proportional share to the permeability characteristics of the membrane.
- the membrane comprises: approximately 34 to about 36 weight percent polysulfone; approximately 42 to about 46 weight percent sulfolane; approximately 10 to about 12 weight percent methoxy-PEG (molecular weight approximately 2,000); approximately 1 to about 1.5 weight percent glycerin; approximately 2 to about 3 weight percent polyvinylpyrrohdone; and approximately 4 to about 7 weight percent n-methyl-pyrrolidone.
- polysulfone compounds and their synthesis are well-known in the art.
- Preferred polysulfone compounds useful in this invention satisfy the formula:
- Ri and R are groups such as alkanes, alkenes, alkynes, aryls, alkyls, alkoxys, aldehydes, anhydrides, esters, ethers, and mixtures thereof, each such group having fifty or fewer carbon atoms and including both straight-chained and branched-chained structures.
- Preferred polysulfone compounds useful in this invention have a melt flow index (MFI) in a range of from about 1.7 dg/min to about 9.0 dg/min as measured according to the American Standard Test
- polysulfone compounds useful in this invention include, but are not limited to polyarylsulfones, for example, bisphenol A polysulfone, polyether sulfone, polyphenyl sulfone, and mixtures thereof.
- a “solvent for the polysulfone compound” is defined herein as a compound having the following characteristics: a boiling point of at least about 150°C, a solvating power to dissolve from about 8 weight percent to about 80 weight percent of the polysulfone compound at a temperature in a range from about 50°C to about 300°C.
- the solvent preferably can dissolve from about 8 weight percent to about 80 weight percent of a polyarylsulfone.
- Candidate solvents useful in this invention include, but are not limited to, tetramethylene sulfone; 3-methyl sulfolane; benzophenone; n,n-dimethylacetamide; 2- pyrrlidone; 3-methylsulfolene; pyridine; thiophene; o-dichlorobenzene; 1- chloronapthalene; methyl salicylate; anisole; o-nitroanisole; diphenly ether; diphenoxy methane; acetophenone; p-methoxyphenyl-2-ethanol; 2-piperidine; antipyrine; diethyl phthalate; diphenyl sulfone; diphenyl sulfoxide; phthalic acid, dioctyl ester; phthalic acid, dimethyl ester; phthalic acid, diethyl ester; phthalic acid, dibutyl ester; phthalic acid, bix(2-ethylhexyl) ester;
- Especially preferred solvents useful in this invention include, but are not limited to, tetramethylene sulfone ("sulfolane”), antipyrine, ⁇ -valerolactam, diethyl phthalate, and mixtures thereof. Especially good results have been achieved utilizing tetramethylene sulfone as the solvent.
- non-solvent for the polysulfone compound is defined herein as a compound having the following characteristics: a boiling point of at least about 150°C, a solvating power sufficiently low to dissolve less than about 5 weight percent of the polysulfone compound at a temperature in a range from about 50°C to about 300°C.
- Candidate non-solvents useful in this invention are 1,1-diethylurea; 1,3- diethylurea; dinitrotoluene; 1,2-ethane diamine; diphenylamine; toluenediamine; o- toluic acid; m-toluic acid; toluene-3,4-diamine; dibutyl phthalate; piperidine; decalin; cyclohexane; cyclohexene; chlorocyclohexane: "cellosolve” solvent; n,n- dimethylbenzylamine; paraffin; mineral oil; mineral wax; tallow amine; triethanol amine; lauryl methacrylate; stearic acid; di(ethylene glycol); tri(ethylene glycol); ethylene glycol; poly(ethylene glycol); tetra(ethylene glycol); glycerin; diethyl adipate; d-sorbitol; chlorotriphenyl stannane;
- the concentrations of the components in the composition may vary and are dependent upon variables many of which can be readily worked out with simple bench experiments. For example, miscibility of the composition at the melt-extrusion temperature is one factor to be considered in determining a suitable component concentration. Miscibility of polysulfone compound solutions can be readily determined empirically by methods known in the art. (Whether or not the components of a composition are miscible is readily apparent.) The end use of the membrane is another factor in determining the appropriate blend composition because the preferred pore size of the membrane and transport rate of liquids and solutes through the membrane vary depending upon the intended fiber end use.
- the concentration of the polysulfone compound is preferably at least about 8 weight percent, more preferably at least about 12 weight percent.
- the concentration of the solvent is preferably at least about 40 weight percent, more preferably at least about 60 weight percent.
- the concentration of the non-solvent, if present, is preferably at least about 1 weight percent, and more preferably at least about 5 weight percent.
- the concentration of the polysulfone compound is preferably at least about 18 weight percent, more preferably at least about 25 weight percent.
- the concentration of the solvent is preferably at least about 40 weight percent, more preferably at least about 45 weight percent.
- Concentration of the non-solvent, if present, is preferably at least about 1 weight percent, more preferably at least about 5 weight percent.
- solvent to non-solvent ratios are preferably about 0.95:1 to about 80:1, and more preferably about 2:1 to about 10:1.
- acceptable amounts of the polysulfone compound, solvent, and non-solvent lie within the area bounded by the extremes of each component which generate the area A, B, C. Any of the specific compositions consisting of an amount of each of the three components within the area A, B, C of Fig. 3 are suitable for melt spinning into hollow-fiber membranes.
- the concentration of polysulfone is preferably at least about 30 weight percent, more preferably at least about 35 weight percent.
- concentration of the solvent is preferably at least about 12 weight percent, more preferably at least about 20 weight percent. If present, the concentration of the non-solvent is preferably at least about 1 weight percent, more preferably at least about 5 weight percent.
- compositions of this invention may be used to fabricate polysulfone semipermeable membranes useful for "liquid-separation processes.” As defined herein, such processes include, but are not limited to, microfiltration, ultrafiltration, dialysis, and reverse osmosis.
- Fig. 5 shows a representative liquid-separation device configured for use as an extracorporeal blood treatment device, specifically a hemodialyzer.
- the hemodialyzer 10 comprises an outer casing 12, end caps 14, a dialysate inlet 16, a dialysate outlet 18, a blood inlet 20, a blood outlet 22, and a bundle of fibers 24 potted in the outer casing.
- the outer casing defines a dialysate compartment and the lumina of the fibers form a blood compartment. As blood flows through the lumina of the fibers in a parallel fashion, dialysate flows counter-currently through the dialysate compartment.
- Membranes of the present invention may be fabricated by alternative method schemes as illustrated in Figs. 1 and 2. A number of method schemes may be followed depending upon the optional method steps chosen to develop the desired polysulfone membrane.
- a polysulfone composition of a UHMW hydrophillic polymer, a polysulfone compound, a solvent, and a non-solvent is precompounded in a high-shear mixer, melted, extruded (as hollow fibers), quenched (Fig. 1), and then wound on cores or reels using any number of commercially available winders, such as Leesona winders. In such a method, adequate care should be taken to maintain a slight tension on the hollow fibers during winding.
- the polysulfone composition is precompounded in a high-shear mixer, melted, extruded through a strand die (to form solid strands), cooled, pelletized, remelted, extruded (to form hollow fibers), quenched, and then wound (Fig. 2).
- the polysulfone composition is precompounded, melted, extruded (as hollow fibers), quenched, wound, held dry for a period of time, soaked in a liquid that is substantially a non-solvent for the polysulfone compound and stored in the soaking liquid for up to 15 days (Fig. 1).
- a polysulfone composition is precompounded in a high-shear mixer, melted, extruded (as hollow fibers), quenched, wound, soaked, leached, rinsed, replasticized, and then dried in an oven (preferably a convection oven) (Fig. 1).
- the polysulfone composition is precompounded, melted, extruded (as solid strands), cooled, pelletized, remelted, extruded (as hollow fibers), quenched, wound, and then held dry in air followed by soaking in a liquid that is substantially a non-solvent for the polysulfone compound (Fig. 2).
- a polysulfone composition is precompounded, melted, extruded (as solid strands), cooled, pelletized, remelted, extruded (as hollow fibers), quenched, wound, soaked, leached, rinsed, replasticized, and dried (Fig. 2).
- the components of the composition i.e., the UHMW hydrophilic polymer, polysulfone compound, solvent, and non-solvent
- the components of the extrusion composition may also be combined and homogenized directly in a meltpot provided with suitable agitation of the molten liquid.
- a polysulfone extrusion composition may be homogenized by extruding a molten composition through a strand die, cooling the global extrudate, and grinding or pelletizing the extrudate to a particle size readily-fed to a heated, single- screw or twin-screw extruder.
- other heating/homogenizing methods known to those skilled in the art may be utilized to produce a homogeneous, molten liquid for extrusion (termed a "melt").
- the melt is heated to a temperature that facilitates preparation of a homogeneous liquid possessing a viscosity suitable for extrusion. The temperature should not be so high as to cause significant degradation of the polysulfone, the solvent, or the non- solvent.
- the extrusion temperature is preferably at least about 50°C, more preferably at least about 75°C.
- the extrusion temperature is preferably less than about 300°C, more preferably less than about 220°C.
- the viscosity of the melt should not be so high as to be too viscous to be extruded at temperatures that do not deleteriously affect the polysulfone compound.
- the viscosity, however, of the melt must not be so low that the extrudate cannot maintain a desired shape upon exiting the extrusion die.
- the melt may be extruded in a variety of shapes such as, but not limited to, hollow-fibers, tubes, sheets, and hollow- fibers with fins.
- the extrudate may be aided in retaining its desired shape upon extrusion by cooling.
- the melt is extruded through a hollow-fiber die (spinneret).
- the spinneret typically is multi-holed and, thus, produces a tow of multiple hollow fibers.
- the spinneret typically includes a means for supplying a fluid (gas or liquid) to the core or "lumen" of the extrudate.
- the core fluid is used to prevent collapse of the hollow fibers as they exit the spinneret.
- the core fluid may be a gas, such as nitrogen, air, carbon dioxide, or other inert gas, or a liquid which is a non- solvent for the polysulfone compound, such as, but not limited to, water, poly(ethylene glycol), di(ethylene glycol), tri(ethylene glycol), glycerol, and mixtures thereof.
- the melt may first be extruded as solid strands through a single or multi-holed strand die and the resulting solid strands cooled and pelletized to a particle size readily fed to a single-screw or twin-screw extruder (Fig. 2).
- Fig. 2 a single-screw or twin-screw extruder
- the particles are remelted and then extruded through a single-holed or multi-holed spinneret to form hollow fibers, as described above.
- the extrudate exiting extrusion die enters one or more quench zones.
- the environment of a quench zone may be gaseous or liquid.
- the extrudate is subjected to sufficient cooling to cause gelation and solidification of the membrane.
- the time period beginning after the extrudate exits the die and extending to before the membrane is wound onto a core or reel, is important to attain the desired permeability of the membrane. During this time period, for a given composition, the permeability of the membrane is determined largely by the cooling rate to which the extrudate is subjected.
- Permeability is increased by rapid quenching of the extrudate, compared to the permeability obtained from a less drastic quench or slower gelling of the extrudate.
- Increasing permeability of the membranes which results from more rapid quenching, normally affects the ability of the membranes to transport water, or other liquids and compounds across the thickness dimension of the membranes.
- the extrudate cooling rate (as affected by the temperature and composition of the cooling medium employed) may be varied to modify the permeability of the resulting membrane.
- a polysulfone hollow-fiber extrudate is quenched in air.
- the hollow fibers gel and solidify.
- the temperature of the air-quench zone is preferably less than about 27°C, more preferably less than about 24°C.
- the hollow fibers are held in the air zone for preferably less than about 180 minutes, more preferably less than about 30 minutes.
- the hollow-fiber extrudate is quenched in a liquid that is substantially a non-solvent for the polysulfone compound, such as water, poly(ethylene glycol), di(ethylene glycol), tri(ethylene glycol), glycerol, or a mixture thereof.
- a liquid quench comprises water and one or more other components, the ratio of water to the other components is preferably from about 0.25:1 to about 200:1.
- the temperature of the liquid quench zone is preferably less than about 50°C, more preferably less than about 25°C, and more preferably less than about 10°C.
- the advantage of a liquid quench is that it offers less resistance to the transfer of heat from the extrudate to the cooling medium than is present in an air quench and, thus, results in a more rapid removal of heat from the extrudate as the membrane forms. The rapid removal of heat modifies the permeability of the resulting membrane and can be used to tailor membrane permeability for the intended end use.
- Hollow fibers are, optionally, drawn using godet rollers or other conventional equipment to the appropriate fiber diameter. More specifically, drawing or stretching the fiber may be accomplished by passing the hollow fiber over a series of rollers. The desired degree of stretching may be obtained by control of the rate of rotation of the second roller or second group of rollers relative to the first roller encountered by the fiber.
- Line speeds are generally not critical and may vary over a wide range. Preferred line speeds are at least about 10 feet per minute and less than about 1000 feet per minute.
- the membrane is passed through at least one leach bath containing a liquid that is substantially a non-solvent for the polysulfone compound, such as water or a mixture of water and sulfolane and/or the non-solvent(s), or a mixture of water and the solvent utilized in the melt composition.
- a liquid that is substantially a non-solvent for the polysulfone compound such as water or a mixture of water and sulfolane and/or the non-solvent(s), or a mixture of water and the solvent utilized in the melt composition.
- Good results have been achieved when the leach bath is water.
- the membrane is leached to remove at least a portion of the solvent and the non-solvent.
- the leach bath need not remove all of the solvent and non-solvent from the membrane, depending, at least in part, on the anticipated end use of the membrane.
- the minimum temperature of the leach bath is such that removal of the solvent and non-solvent from the membrane occurs at a reasonable rate relative to production rate demands.
- the minimum temperature of the leach bath is preferably at least about 20°C, more preferably at least about 40°C.
- the maximum temperature of the leach bath is below a temperature at which the integrity of the membrane is deleteriously affected. Accordingly, the temperature of the leach bath is preferably less than about 95°C.
- the residence time of a hollow-fiber membrane in the leach bath is preferably less than about 1200 seconds, more preferably less than about 300 seconds.
- the hollow fiber may, optionally, be drawn to the desired size prior to entrance into the leach bath, during the residence time in the leach bath, subsequent to exiting the leach bath, or during any combination thereof.
- the membrane may, optionally, be passed through a rinse bath containing water.
- the rinse bath removes residues in the membrane from the leach process.
- the rinse bath is preferably maintained at room temperature.
- the residence time of the fiber within the rinse bath is preferably less than 1200 seconds, more preferably less than 300 seconds.
- the membrane may then be subjected to a replasticization process.
- a replasticization bath is used that preferably contains less than about 50 weight percent glycerol and more preferably less than about 45 weight percent glycerol, with the balance being water.
- the minimum temperature of the replasticization bath is such that replasticization of the membrane occurs at reasonable rate relative to production demands.
- the minimum temperature of a glycerol-containing replasticization bath is preferably at least about 20°C, more preferably at least about 35°C.
- the maximum temperature of the replasticization bath is below a temperature at which the membrane integrity could be adversely affected. Accordingly, the maximum temperature of the replasticization bath is preferably less than about 100°C, more preferably less than about 50°C.
- excess liquid adliering to the membrane may optionally be removed, preferably by use of a conventional air knife operating at a pressure of about 10 psig to about 60 psig. With hollow fibers, good results have been achieved when the air knife is maintained at a pressure of about 30 psig.
- the resulting polysulfone membrane may, optionally, be dried in an oven (preferably a convection oven).
- the oven is maintained at a temperature of from about 20°C to about 200°C.
- good results have been achieved when the temperature of the oven is about 70°C.
- the membrane is dried for a period of from about 5 seconds to about 1200 seconds.
- goods results have been achieved when the fiber was dried for at least about 140 seconds.
- the semipermeable polysulfone membranes formed by the described methods may be used in liquid-separation processes such as, but not limited to, microfiltration, ultrafiltration, dialysis, and reverse osmosis.
- the specific fabrication method that is employed, within the scope of methods according to the present invention, is selected so as to tailor the resulting membrane for its anticipated end use. Such adaption is readily achieved by one skilled in the art based upon the teachings herein.
- a composition was prepared comprising about 36 weight percent Udel P1835NT11, a brand of bisphenol A polysulfone (available from Amoco Polymers, Inc. of Alpharetta, Georgia) about 44.3 weight percent anhydrous sulfolane (available from Phillips Chemical Company of Borger, Texas) and about 17.7 weight percent poly(ethylene glycol) having an average molecular weight of about 1000 daltons (available from Dow Chemical Company of Midland, Michigan).
- the solvent to non- solvent ratio was about 2.5:1.
- the composition was compounded in a co-rotating twin- screw extruder at about 132°C. The extruded composition was cooled, pelletized using an RCP 2.0 pelletizer (available from Randcastle Extrusion Systems, Inc.
- the resulting hollow-fiber extrudate was quenched in air at about 21°C for about 15 seconds, drawn from a first godet (rotating at a surface speed of 172 feet per minute) to a second godet (rotating at a surface speed of 182 feet per minute) to increase the fiber's length by about 5.75 percent, wound on a core, and soaked in a water bath at a temperature of about 25 °C for about four hours.
- the hollow fiber was processed by unwinding the fiber from the core at a rate of about 30 ft/ in and passing the fiber through a 37°C water bath for about 40 seconds. The fiber was then immersed in a room temperature water-rinse bath for 139 seconds. Following the rinse bath, the fiber was replasticized by immersion for 140 seconds in a 40-percent aqueous glucerol replasticization bath held at about 37°C. After removing the fiber from the aqueous glycerol bath, excess liquid was removed from the fiber using an air knife operating at about 30 psig. The processed hollow fiber was then dried in a convection oven at about 70°C for 155 seconds.
- the resulting hollow fiber had an average lumen diameter of 160 ⁇ m, and an average wall thickness of 18 ⁇ m.
- the hollow fiber was fabricated into a dialysis test unit containing 150 fibers.
- the in vitro water flux of the device was 102.5 mL/ (hr*mmHg » m ) and the average K oV for sodium chloride was found to be 1.92 x 10 " centimeters per minute at a solution flow rate through the fiber lumina of about 0.02 milliliters per minute per fiber.
- Ko V is defined in the following equation: +
- K is the resistance to mass transfer within the fluid present in the lumen of the hollow fiber
- P m is the membrane permeability
- This hollow-fiber membrane could be fabricated into a suitable device for use as an ultrafiltration cell for the removal of contaminants from water of aqueous solutions.
- P1835NT11 polysulfone (Amoco Polymers, Inc.), about 45.7 weight percent anhydrous sulfolane (Phillips Chemical), and about 18.3 weight percent poly(ethylene glycol) having an average molecular weight of about 1000 daltons (Dow Chemical), yielding a solvent to non-solvent ratio about 2.5:1.
- the composition was compounded in a co- rotating, twin-screw extruder at about 173°C.
- the extruded composition was then pelletized, remelted, and extruded through a 30-hole hollow-fiber spinneret at about 178°C using a single-screw extruder.
- the resulting hollow-fiber extrudate was quenched in air at about 22°C for 7-8 seconds.
- the resulting hollow-fiber membrane was wound on a core at about 110 feet per minute, and held dry for about one hour.
- the hollow fiber was then placed in a water bath maintained at a temperature of about 25°C for a period of about 12
- the hollow fiber was then processed by unwinding the fiber from the core at about 30 ft/min and passing the fiber through a 36°C water leach bath for about 40 seconds.
- the fiber was immersed in a room temperature water-rinse bath for 139 seconds.
- the fiber was replasticized for 140 seconds in a 37°C bath of about 40 weight percent aqueous glycerol.
- excess liquid was stripped from the fiber using an air knife operating at a pressure of about 30 psig.
- the processed fiber was then dried in a convection oven at about 70°C for 155 seconds.
- the resulting hollow fiber had an average lumen diameter of about 142 ⁇ m and an average wall thickness of about 31 ⁇ m.
- Dialysis test units each containing 150 of the hollow fibers were fabricated.
- the average in vitro water flux of these devices was 68.0 mL/(l-ff , mrnHg' » m 2 ) and the average Ko V for sodium chloride was about 2.28 x 10 "2 centimeters per minute at a solution flow rate through the fiber lumina of about 0.02 milliliters per minute per fiber.
- This hollow-fiber membrane is useful for ultrafiltration, such as for use in an ultrafiltration cell for the removal of contaminants from water or aqueous solutions.
- EXAMPLE 3 A composition was prepared comprising about 38 weight percent Udel P1835NT11 polysulfone (Amoco Polymers, Inc.), about 44.3 weight percent anhydrous sulfolane (Phillips Chemical), and about 17.7 weight percent poly(ethylene glycol) having an average molecular weight of about 1000 daltons (Dow Chemical), yielding a solvent to non-solvent ratio about 2.5:1.
- the composition was compounded in a co- rotating, twin-screw extruder at about 99°C, and extruded directly through a 30-hole hollow-fiber spinneret. The extrudate was quenched in air at about 26°C for about 6 seconds. The resulting hollow-fiber membrane was wound on a core at about 160 feet per minute, and placed immediately into a water bath for a period of about 12-15 hours.
- the hollow fiber was then unwound from the core at about 30 ft/min and passed through a 37°C water leach bath for about 40 seconds.
- the fiber was then immersed in a room temperature water-rinse bath for about 140 seconds.
- the fiber was replasticized for 140 seconds in an aqueous glycerol bath containing about 40 weight percent glycerol, the bath being held at about 38°C.
- excess liquid was removed from the fiber by an air knife operating at a pressure of about 30 psig.
- the fiber was then dried in a convection oven at about 70°C for about 155 seconds.
- the resulting hollow-fiber membrane had an average lumen diameter of about
- a composition was prepared comprising about 38 weight percent Udel P1835NT11 polysulfone (Amoco Polymers, Inc.), about 45.7 weight percent anhydrous sulfolane (Phillips Chemical), and about 18.3 weight percent poly(ethylene glycol) having an average molecular weight of about 1000 daltons (Dow Chemical), yielding a solvent to non-solvent ratio about 2.6:1.
- the composition was compounded in a co- rotating, twin-screw extruder at about 143°C, and extruded directly through a 30-hole hollow-fiber spinneret. The extrudate was quenched in air at about 25°C for about 0.08 minutes, wound on a core at about 203 feet per minute, and held dry for thirty minutes before being placed in a 25°C water bath for about three days.
- the hollow fiber was then unwound from the core at about 30 ft/min and passed through a 38°C water leach bath for about 30 seconds.
- the fiber was immersed in a room temperature water-rinse bath for 148 seconds.
- the fiber was replasticized for 149 seconds in an aqueous glycerol bath containing about 40 weight percent aqueous glycerol, the bath being held at about 38°C.
- excess liquid was removed from the fiber using an air knife operating at a pressure of about 30 psig.
- the processed hollow fiber was dried in a convection oven at about 70°C for 147 seconds.
- the resulting hollow fiber membrane had an average lumen diameter of about 192 ⁇ m, and an average wall thickness of about 29.5 ⁇ m.
- Dialysis test units each containing 150 of the resulting fibers were fabricated.
- the average in vitro water flux of these devices was 141.2 mL/(hr « mn ⁇ Hg-»m 2 ) and the average K-o,* for sodium chloride was found to be 1.20 x 10 "2 centimeters per minute at a solution flow rate through the fiber lumina of about 0.02 milliliters per minute per fiber.
- This hollow-fiber membrane is useful in an ultrafiltration cell for the removal of contaminants from water or aqueous solutions.
- a composition was prepared comprising about 34 weight percent Udel P1835NT11 polysulfone (Amoco Polymers, Inc.), about 54 weight percent anhydrous sulfolane (Phillips Chemical), about 12 weight percent poly(ethylene glycol) having an average molecular weight of about 1000 daltons (Dow Chemical), and about 1 weight percent glycerol (NanWaters & Rogers, Inc., Seattle, Washington), yielding a solvent to non-solvent ratio about 4.5:1.
- the composition was compounded in a co-rotating, twin- screw extruder at about 144°C.
- the extrudate was then cooled, pelletized, remelted, and extruded through a 30-hole hollow-fiber spinneret at about 134°C using a single-screw extruder.
- the resulting extrudate was quenched in air at about 20°C for 0.08 minute, and wound on a core at about 200 feet per minute. The entire wound core was immediately placed in a 25°C water bath for a period of about 15-20 hours.
- the hollow fiber was then processed by unwinding the fiber from the core at about 30 ft/min and passing the fiber through a room-temperature water-leach bath for 97 seconds.
- the fiber was replasticized for 145 seconds in a bath containing about 40 weight percent aqueous glycerol held at about 38°C. After removing the fiber from the aqueous glycerol bath, excess liquid was stripped from the fiber using an air knife operating at a pressure of about 30 psig.
- the processed hollow fiber was dried in a convection oven at about 62°C for 151 seconds.
- the resulting hollow-fiber membrane had an average lumen diameter of about 165 ⁇ m, and an average wall thickness of about 18 ⁇ m.
- Test units each containing about 150 of the resulting fibers were fabricated.
- the average in vitro water flux of these devices was 67.2 mL/(hr » mmHg*m 2 ) and the average K ⁇ v for sodium chloride was found to be 2.19 x 10 "2 centimeters per minute at a solution flow rate through the fiber lumina of about 0.02 milliliters per minute per fiber.
- P1835NT11 polysulfone (Amoco Polymers, Inc.), about 54 weight percent anhydrous sulfolane (Phillips Chemical), about 6 weight percent poly(ethylene glycol) having an average molecular weight of about 1000 daltons (Dow Chemical), and about 6 weight percent tri(ethylene glycol) (Aldrich Chemical Company, Inc., Milwaukee, Wisconsin), yielding a solvent to non-solvent ratio about 9:1.
- the composition was compounded in a co-rotating, twin-screw extruder at about 153°C.
- the extrudate was then cooled, pelletized, remelted, and extruded through a 30-hole hollow-fiber spinneret at about 137°C using a single-screw extruder.
- the resulting hollow-fiber extrudate was quenched in air at about 20°C for 0.08 minute, and wound on a core at about 200 feet per minute.
- the entire fiber core was immediately placed in a 25°C water bath for a period of
- the hollow fiber was then processed by unwinding the fiber from the core at about 30 ft/min and passing the fiber through a room-temperature water-leach bath for 95 seconds. The fiber was then immersed in a room temperature water-rinse bath for
- the hollow fiber was replasticized for 146 seconds in a bath of about 40 weight percent aqueous glycerol held at about 38°C. After removing the fiber from the aqueous glycerol bath, excess liquid was stripped from the fiber using an air knife operating at a pressure of about 30 psig. The processed fiber was dried in a convection oven at about 70°C for 150 seconds.
- the resulting hollow-fiber membrane had an average lumen diameter of about 180 ⁇ m, and an average wall thickness of about 20 ⁇ m.
- Test units each containing about 150 of the resulting fibers were fabricated.
- the average in vitro water flux of these devices was 60.0 mL/(hr » mmHg»m 2 ) and the average K_, v for sodium chloride was found to be 2.17 x 10 "2 centimeters per minute at a solution flow rate through the fiber lumina of about 0.02 milliliters per minute per fiber.
- a composition was prepared comprising about 32 weight percent Udel P1835NT11 polysulfone (Amoco Polymers, Inc.), about 53 weight percent anhydrous sulfolane (Phillips Chemical), and about 15 weight percent poly(ethylene glycol) having an average molecular weight of about 1000 daltons (Dow Chemical), yielding a solvent to non-solvent ratio about 3.5:1.
- the composition was compounded in a co-rotating twin-screw extruder at about 131°C and extruded directly through a 30-hole hollow- fiber spinneret. The extrudate was quenched in water at about 7°C for about 6 seconds.
- the resulting hollow-fiber membranes were wound on a core at about 244 feet per minute.
- the entire fiber core was immediately placed in a 25°C water bath for a period of about 15-20 hours.
- the hollow fibers were then processed by unwinding the fibers from the core at about 30 ft/min and passing the fibers through a room-temperature water-leach bath for
- the fibers were replasticized for 146 seconds in a bath of about 40 weight percent aqueous glycerol, the bath being held at about 38°C. After removing the fibers from the aqueous glycerol bath, excess liquid was stripped from the fiber using an air knife operating at a pressure of about 20 psig. The processed fibers were dried in a convection oven at about 45°C for 152 seconds.
- the resulting hollow-fiber membranes had an average lumen diameter of about 203 ⁇ m, and an average wall thickness of about 37 ⁇ m.
- Test units each containing about 150 of the resulting fibers were fabricated.
- the average in vitro water flux of these devices was 9.1 mL/(hr « mmHg « m 2 ) and the average K oV for sodium chloride was found to be 1.76 x 10 " centimeters per minute at a solution flow rate through the fiber lumina of about 0.02 milliliters per minute per fiber.
- Ca m and C ⁇ out are the concentration of solute at blood inlet and outlet.
- Middle solute clearances such as vitamin B12, and cytochrome-C were determined using closed loop circuit at the same flow rates as in the case of small solute clearance with the solute concentration in the range of 300 to 500 ppm.
- the clearance was calculated as follows:
- V volume of the reservoir at time zero
- Qf ultrafiltration rate
- Bovine serum is used in these tests.
- the total protein content is 60 ⁇ 5 g 1.
- the slope of Qf versus the trans membrane pressure, (TMP - mmHg) is used for the computation of Kuf.
- Kuf (Qfx 60) / TMP , ml/h mmHg
- the albumin sieving coefficient, S is obtained by means of the expression:
- Cp is the concentration of solute in the ultrafiltrate.
- Fresh bovine blood is used in this test.
- the dialyzers, including membranes, to be tested for platelet drop are primed with IL of saline solution then attached to the dialyzer into the test system as shown in Fig. 8.
- 500 ml of blood maintained at 37 ⁇ 1°C was used for each test.
- Blood was recirculated at 300 ml/min with closed dialysate ports. Blood samples, 1 ml each, were collected at 0, 1, 15, 30, 60, 90, 120, and 180 minutes for platelet counts by means of a Coulter Differential Cell Counter. The average value of two readings was used to assess the platelet variation versus recirculation time.
- polysulfone fiber A was spun from a formulation consisting of:
- Glycerin 1.2 wt%
- Polyvinylyrrolidone 1.0 wt%
- UHMW Polyvinylyrrolidone
- a composition comprising about 37.6 weight percent Udel polysulfone, about 49.2 weight percent anhydrous sulfolane, about 11.0 weight percent polyethylene glycol, about 1.2 weight percent glycerin, and about 1.0 % UHMW polyvinylpyrrolidone.
- the composition was compounded in a co-rotating, twin screw extruder about 160°C, and then extruded through a 16-hole hollow fiber spinneret at about 145°C. The extrudate was quenched in the air at about 18°C for about 30 seconds.
- the resulting hollow-fiber membrane was wound on a core at about 200 m min, after being passed through a water bath at about 37°C for about 10 seconds.
- the hollow fiber membrane was then unwound from the core at about 60 ft/min and passed through a 40°C water bath for about 150 seconds.
- the fiber was replasticized for about 30 seconds in an aqueous glycerol bath containing about 40 weight percent glycerol, the bath temperature was about 38°C.
- excess liquid was removed from the fiber by an air knife operating at a pressure of about 12 psig.
- the fiber was then dried in a convection oven at about 70°C for about 200 seconds and wound on a core at about 60 ft/min.
- the obtained fiber shows a symmetric structure as illustrated in Figs. 6 and 7.
- Fiber dimension and functional performance is given in Table I below.
- In-vitro platelet results tested with bovine blood are shown in Fig. 9. There was no drop in platelet after 3 hours of recirculation.
- polysulfone fiber B was spun from a formulation consisting of:
- Glycerin 1.3 wt%
- Sulfolane 51.2 wt%
- Polyvinylpyrrolidone (UHMW) 0 wt%
- a composition comprising about 36.0 weight percent Udel polysulfone, about 51.2 weight percent anhydrous sulfolane, about 11.5 weight percent polyethylene glycol, and about 1.3 weight percent glycerin.
- the composition was compounded in a co-rotating, twin screw extruder about 160°C, and then extruded through a 16-hole hollow fiber spinneret at about 145°C. The extrudate was quenched in the air at about 18°C for about 30 seconds.
- the resulting hollow-fiber membrane was wound on a core at about 200 m/min, after being passed through a water bath at about 37°C for about 10 seconds.
- the hollow fiber membrane was then unwound from the core at about 60 ft/min and passed through a 40°C water bath for about 150 seconds.
- the fiber was replasticized for about 30 seconds in an aqueous glycerol bath containing about 40 weight percent glycerol, the bath temperature was about 38°C.
- excess liquid was removed from the fiber by an air knife operating at a pressure of about 12 psig.
- the fiber was then dried in a convection oven at about 70°C for about 200 seconds and wound on a core at about 60 ft/min.
- the obtained fiber shows a symmetric structure as illustrated in Figs. 6 and 7.
- Fiber dimension and functional performance is given in Tables I and II.
- In-vitro platelet results using bovine blood are shown in Fig. 9. The platelet reduction was approximately 40% after 3 hours of recirculation.
- composition comprising about 36.0 weight percent Udel polysulfone, about 44.2 weight percent anhydrous sulfolane, about 11.0 weight percent polyethylene glycol, about 1.3 weight percent glycerin, 5.0 weight percent NMP, and about 2.5 % UHMW polyvinylpyrrolidone.
- the composition was compounded in a co-rotating, twin screw extruder about 160°C, and then extruded through a 16-hole hollow fiber spinneret at about 145°C. The extrudate was quenched in the air at about 18°C for about 30 seconds.
- the resulting hollow-fiber membrane was wound on a core at about 200 m min, after being passed through a water bath at about 37°C for about 10 seconds.
- the hollow fiber membrane was then unwound from the core at about 60 ft/min and passed through a 40°C water bath for about 150 seconds.
- the fiber was replasticized for about 30 seconds in an aqueous glycerol bath containing about 40 weight percent glycerol, the bath temperature was about 38°C. After removing the fiber from the aqueous glycerin bath, excess liquid was removed from the fiber by an air knife operating at a pressure of about 12 psig.
- the fiber was then dried in a convection oven at about 70°C for about 200 seconds and wound on a core at about 60 ft/min.
- the obtained fiber shows a symmetric structure as illustrated in Figs. 6 and 7.
- Fiber dimension and functional performance is given in Tables I and II.
- In-vitro platelet results tested with bovine blood are shown in Fig. 9. There was no drop in platelet after 3 hours of recirculation.
- polysulfone fiber D was spun from a formulation consisting of:
- Glycerin 1.2 wt%
- Polyvinylpyrrolidone (UHMW) 2.1 wt%
- N-Methyl-pyrrolidone 7.2 wt%
- a composition was prepared comprising about 35.0 weight percent Udel polysulfone, about 43.2 weight percent anhydrous sulfolane, about 11.0 weight percent polyethylene glycol, about 1.2 weight percent glycerin, 7.2 weight percent NMP, and about 2.1 % UHMW polyvinylpyrrolidone.
- the composition was compounded in a co-rotating, twin screw extruder about 160°C, and then extruded through a 16-hole hollow fiber spinneret at about 145°C. The extrudate was quenched in the air at about 18°C for about 30 seconds.
- the resulting hollow-fiber membrane was wound on a core at about 200 m/min, after passed through a water bath at about 37°C for about 10 seconds.
- the hollow fiber membrane was then unwound from the core at about 60 ft/min and passed through a 40°C water bath for about 150 seconds.
- the fiber was replasticized for about 30 seconds in an aqueous glycerol bath containing about 40 weight percent glycerol, the bath temperature was about 38°C.
- excess liquid was removed from the fiber by an air knife operating at a pressure of about 12 psig.
- the fiber was then dried in a convection oven at about 70°C for about 200 seconds and wound on a core at about 60 ft/min.
- the obtained fiber shows a symmetric structure as illustrated in Figs. 6 and 7.
- Fiber dimension and functional performance is given in Tables I and II.
- In-vitro platelet results tested with bovine blood are shown in Fig. 9. There was no drop in platelet after 3 hours of recirculation.
- Fiber ID Fiber ID
- Fiber Wall Water Permeability, Strength at break
- Polysulfone Fiber micron micron ml h/m2/mmHg g/cm2
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- External Artificial Organs (AREA)
- Artificial Filaments (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002511116A CA2511116A1 (en) | 2002-12-20 | 2003-12-18 | Melt-spun polysulfone semipermeable membranes and methods for making the same |
BR0317533-2A BR0317533A (en) | 2002-12-20 | 2003-12-18 | Semi-permeable polysulfone "melt spun" membranes and methods for making them |
AU2003301102A AU2003301102A1 (en) | 2002-12-20 | 2003-12-18 | Melt-spun polysulfone semipermeable membranes and methods for making the same |
EP03814186A EP1572331A1 (en) | 2002-12-20 | 2003-12-18 | Melt-spun polysulfone semipermeable membranes and methods for making the same |
MXPA05006768A MXPA05006768A (en) | 2002-12-20 | 2003-12-18 | Melt-spun polysulfone semipermeable membranes and methods for making the same. |
JP2004563792A JP2006511330A (en) | 2002-12-20 | 2003-12-18 | Melt-spun polysulfone semipermeable membrane and method for making the semipermeable membrane |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/327,564 US7144505B2 (en) | 1997-09-18 | 2002-12-20 | Melt-spun polysulfone semipermeable membranes and methods for making the same |
US10/327,564 | 2002-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004058385A1 true WO2004058385A1 (en) | 2004-07-15 |
WO2004058385A9 WO2004058385A9 (en) | 2004-11-25 |
Family
ID=32680758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/040499 WO2004058385A1 (en) | 2002-12-20 | 2003-12-18 | Melt-spun polysulfone semipermeable membranes and methods for making the same |
Country Status (10)
Country | Link |
---|---|
US (1) | US7144505B2 (en) |
EP (1) | EP1572331A1 (en) |
JP (1) | JP2006511330A (en) |
KR (1) | KR20050086929A (en) |
CN (1) | CN1729044A (en) |
AU (1) | AU2003301102A1 (en) |
BR (1) | BR0317533A (en) |
CA (1) | CA2511116A1 (en) |
MX (1) | MXPA05006768A (en) |
WO (1) | WO2004058385A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1790364A1 (en) * | 2004-08-06 | 2007-05-30 | Asahi Kasei Medical Co., Ltd. | Polysulfone hemodialyzer |
ITBO20090472A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | ARTIFICIAL KIDNEY WEARABLE WITH REGENERATIVE SYSTEM |
ITBO20090471A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | ARTIFICIAL KIDNEY WEARABLE WITH REGENERATIVE SYSTEM |
ITBO20090473A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | DIALYSIS MACHINE WITH REGENERATIVE SYSTEM |
ITBO20090474A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | EMOFILTRATION MACHINE WITH REGENERATIVE SYSTEM |
EP2277572A1 (en) * | 2009-07-22 | 2011-01-26 | Bellco S.r.l. | Dialysis machine with regeneration system |
EP2281591A1 (en) * | 2009-07-22 | 2011-02-09 | Bellco S.r.l. | Wearable artificial kidney with regeneration system |
EP2365022A1 (en) | 2010-03-11 | 2011-09-14 | Gambro Lundia AB | Graft copolymers |
WO2013034611A1 (en) * | 2011-09-08 | 2013-03-14 | Gambro Lundia Ab | Hollow fiber membrane |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1635933T3 (en) * | 2003-06-02 | 2011-06-20 | Ge Osmonics Inc | Materials and Methods for Processing Non-Aqueous Mixtures |
CN1829564B (en) * | 2003-06-02 | 2010-12-15 | Ge奥斯莫尼克斯公司 | Material for processing non-aqueous mixtures and methods for their preparation |
WO2005046439A2 (en) * | 2003-11-07 | 2005-05-26 | Nxstage Medical, Inc. | Improved methods and apparatus for leak detection in blood processing systems |
US9254279B2 (en) * | 2004-05-12 | 2016-02-09 | Baxter International Inc. | Nitric oxide scavengers |
US20070036929A1 (en) * | 2005-08-09 | 2007-02-15 | The Boeing Company | Thin film applique |
US8147735B2 (en) * | 2008-07-09 | 2012-04-03 | Eltron Research & Development, Inc. | Semipermeable polymers and method for producing same |
AU2011225316B2 (en) | 2010-03-09 | 2014-04-17 | Toyobo Co., Ltd. | Porous, hollow fiber membrane for liquid treatment containing protein |
US9364797B2 (en) * | 2010-09-14 | 2016-06-14 | Council Of Scientific & Industrial Research | High flux hollow fiber ultrafiltration membranes and process for the preparation thereof |
CN103031609B (en) * | 2012-12-20 | 2015-01-21 | 天邦膜技术国家工程研究中心有限责任公司 | Shaping core liquid system of hollow fibrous membrane central hole |
CA2908503C (en) * | 2013-04-01 | 2021-12-21 | Petroliam Nasional Berhad | Polysulfone membrane having high selectivity |
CN103804911A (en) * | 2014-02-27 | 2014-05-21 | 苏州市涵信塑业有限公司 | Improved PSU (Polysulphone) plastic |
CN108137931B (en) * | 2015-10-16 | 2021-06-08 | 住友化学株式会社 | Resin solution composition |
CN106943884B (en) * | 2017-04-07 | 2019-08-02 | 苏州灵岩医疗科技股份有限公司 | A kind of preparation method of anti-coagulation type polysulfones dialysis membrane |
CN109173753A (en) * | 2018-09-20 | 2019-01-11 | 中国乐凯集团有限公司 | Casting solution, ultrafiltration membrane, reverse osmosis composite membrane or Nano filtering composite membrane |
CN110508136B (en) * | 2019-09-11 | 2021-08-17 | 南通大学 | Preparation method of high-flux reverse osmosis membrane |
KR102337165B1 (en) * | 2020-05-21 | 2021-12-07 | 도레이첨단소재 주식회사 | Composition of Polyphenylene sulfide porous hollow fiber membrane having sponge like structure, PPS porous hollow fiber membrane containing the same and Manufacturing method thereof |
CN114307652B (en) * | 2021-12-23 | 2022-09-16 | 中南大学湘雅医院 | Thiophosphoric acid blood purification modified membrane and preparation method thereof |
US11826711B2 (en) * | 2022-02-23 | 2023-11-28 | Hamilton Sundstrand Corporation | Regenerable organic contaminant controller in space application |
CN115260224B (en) * | 2022-08-04 | 2024-04-02 | 浙江锦华新材料股份有限公司 | Method for producing vinyl tributyl ketoximino silane by supergravity method |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0568045A1 (en) * | 1992-04-29 | 1993-11-03 | Kuraray Co., Ltd. | Polysulfone-based hollow fiber membrane and process for manufacturing the same |
EP0716859A2 (en) * | 1994-12-16 | 1996-06-19 | TOYO BOSEKI KABUSHIKI KAISHA Trading under the name of Toyobo Co., Ltd. | Module for blood purification blood purification, membrane and its production |
EP0750938A1 (en) * | 1995-06-30 | 1997-01-02 | Toray Industries, Inc. | Polysulfone hollow fiber semipermeable membrane |
EP0764461A1 (en) * | 1994-06-07 | 1997-03-26 | Mitsubishi Rayon Co., Ltd. | Porous polysulfone membrane and process for producing the same |
US5762798A (en) * | 1991-04-12 | 1998-06-09 | Minntech Corporation | Hollow fiber membranes and method of manufacture |
WO1998029478A1 (en) * | 1996-12-31 | 1998-07-09 | Althin Medical, Inc. | Melt-spun polysulfone semipermeable membranes and methods for making the same |
DE19817364C1 (en) * | 1998-04-18 | 1999-07-08 | Fresenius Medical Care De Gmbh | Hydrophilic asymmetric membrane used in ultrafiltration and reverse osmosis |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3763055A (en) | 1971-07-07 | 1973-10-02 | Us Interior | Microporous support for reverse osmosis membranes |
US3993560A (en) | 1975-02-27 | 1976-11-23 | Halpern Richard M | Method and apparatus for monitoring cellular activities |
US4276173A (en) | 1977-07-05 | 1981-06-30 | Cordis Dow Corp. | Cellulose acetate hollow fiber and method for making same |
SE8006102L (en) | 1980-09-02 | 1982-03-03 | Gambro Ab | SET TO RECOVER A PEPTIDE-INHALING ASSOCIATION AND Means FOR IMPLEMENTATION OF THE SET |
JPS5794310A (en) | 1980-12-05 | 1982-06-11 | Daicel Chem Ind Ltd | Production of semipermeable membrane made of polysulfone |
DE3149976A1 (en) | 1981-12-17 | 1983-06-30 | Hoechst Ag, 6230 Frankfurt | MACROPOROUS ASYMMETRIC HYDROPHILE MEMBRANE MADE OF SYNTHETIC POLYMER |
JPS59189903A (en) | 1983-04-09 | 1984-10-27 | Kanegafuchi Chem Ind Co Ltd | Hollow yarn like filter and preparation thereof |
CA1263572A (en) | 1984-06-15 | 1989-12-05 | Kenichi Ikeda | Sulfonated polysulfone composite semipermeable membranes and process for producing the same |
US4906375A (en) * | 1984-07-14 | 1990-03-06 | Fresenius, Ag | Asymmetrical microporous hollow fiber for hemodialysis |
JPH0611328B2 (en) | 1984-10-11 | 1994-02-16 | 株式会社クラレ | Method for treating liquid using porous hollow fiber to which physiologically active substance is immobilized |
WO1986002575A1 (en) | 1984-10-30 | 1986-05-09 | Teijin Limited | Permselective hollow yarn membrane, method of producing the same, method of separating plasma components, and plasma component separator |
JPH0642905B2 (en) | 1986-06-13 | 1994-06-08 | 東レ株式会社 | Hemodialysis membrane |
JPS62298536A (en) | 1986-06-17 | 1987-12-25 | Green Cross Corp:The | Method for automatic purification of preformed chemical mediator and automatic purifying device therefor |
NL8602402A (en) | 1986-09-23 | 1988-04-18 | X Flow Bv | METHOD FOR MANUFACTURING HYDROFILE MEMBRANES AND SIMILAR MEMBRANES |
US4900449A (en) | 1987-05-20 | 1990-02-13 | Gelman Sciences | Filtration membranes and method of making the same |
US4964990A (en) | 1987-05-20 | 1990-10-23 | Gelman Sciences, Inc. | Filtration membranes and method of making the same |
EP0294737B1 (en) | 1987-06-12 | 1994-09-21 | Kuraray Co., Ltd. | Polysulfone hollow fiber membrane and process for making the same |
DE3829766A1 (en) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | METHOD FOR PRODUCING MEMBRANES |
US4970034A (en) | 1988-09-23 | 1990-11-13 | W. R. Grace & Co.-Conn. | Process for preparing isotropic microporous polysulfone membranes |
US5062866A (en) | 1988-10-13 | 1991-11-05 | Exxon Research And Engineering Co. | Polymeric membrane and process for separation of aliphatically unsaturated hydrocarbons |
WO1990004609A1 (en) | 1988-10-17 | 1990-05-03 | Sepracor, Inc. | Process for the covalent surface modification of hydrophobic polymers and articles made therefrom |
CA2001720C (en) | 1988-10-31 | 2001-10-02 | Randal A. Goffe | Membrane affinity apparatus and purification methods related thereto |
CA2006641A1 (en) | 1988-12-29 | 1990-06-29 | Sasaki Isao | Methacrylimide-containing polymer and resin composition containing said polymer |
US4980063A (en) | 1989-01-27 | 1990-12-25 | The Dow Chemical Company | Compositions useful for preparing cellulose ester membranes for liquid separations |
NL8901090A (en) | 1989-04-28 | 1990-11-16 | X Flow Bv | METHOD FOR MANUFACTURING A MICROPOROUS MEMBRANE AND SUCH MEMBRANE |
US5049169A (en) | 1989-05-23 | 1991-09-17 | Nippon Steel Corporation | Polysulfone separation membrane |
DE69132403T2 (en) | 1990-03-27 | 2001-03-29 | Toray Industries, Inc. | COMPOSED MEMBRANE |
US5131928A (en) | 1990-04-09 | 1992-07-21 | The Standard Oil Company | High pressure facilitated membranes for selective separation and process for the use thereof |
US5698101A (en) | 1990-07-09 | 1997-12-16 | Memtec Limited | Hollow fiber membranes |
US5055631A (en) | 1990-07-11 | 1991-10-08 | Exxon Research & Engineering Company | Sulfonated polysulfone membranes for aromatics/saturates separation |
US5102917A (en) | 1990-09-14 | 1992-04-07 | Cpc Engineering Corporation | Porous polysulfone media suitable for filtration |
US5443727A (en) | 1990-10-30 | 1995-08-22 | Minnesota Mining And Manufacturing Company | Articles having a polymeric shell and method for preparing same |
US5418061A (en) | 1990-11-27 | 1995-05-23 | W. R. Grace & Co.-Conn. | Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol |
US5187010A (en) | 1990-11-27 | 1993-02-16 | W. R. Grace & Co.-Conn. | Membrane having high affinity for low density lipoprotein-cholesterol from whole blood |
US5236644A (en) | 1990-11-27 | 1993-08-17 | W. R. Grace & Co.-Conn. | Process of making membrane for removal of low density lipoprotein-cholesterol from whole blood |
US5071448A (en) | 1990-12-05 | 1991-12-10 | Union Carbide Industrial Gases Technology Corporation | Semipermeable membranes based on certain sulfonated substituted polysulfone polymers |
US5151227A (en) * | 1991-03-18 | 1992-09-29 | W. R. Grace & Co.-Conn. | Process for continuous spinning of hollow-fiber membranes using a solvent mixture as a precipitation medium |
JP3097149B2 (en) | 1991-03-28 | 2000-10-10 | 東レ株式会社 | Medical dialysis module and method of manufacturing the same |
DE4112508A1 (en) | 1991-04-17 | 1992-10-22 | Akzo Nv | SYNTHETIC HYDROPHILIC MEMBRANES AND METHOD FOR THE PRODUCTION THEREOF |
US5279739A (en) | 1991-08-19 | 1994-01-18 | Koch Membrane Systems, Inc. | Durable filtration membrane having optimized molecular weight |
US5151222A (en) | 1991-08-26 | 1992-09-29 | Mcdonnell Douglas Corporation | Foam absorber |
JPH05148383A (en) | 1991-10-03 | 1993-06-15 | Mitsubishi Rayon Co Ltd | Polysulfone-based porous film and its preparation |
JPH05262910A (en) | 1992-03-18 | 1993-10-12 | Mitsubishi Rayon Co Ltd | Polysulfone foam having fine open-cell structure and its production |
DE4217335C2 (en) * | 1992-05-26 | 1996-01-18 | Seitz Filter Werke | Hydrophilic membrane and process for its manufacture |
US5232601A (en) | 1992-05-29 | 1993-08-03 | W. R. Grace & Co.-Conn. | High flux hollow fiber membrane |
DE4220441A1 (en) | 1992-06-23 | 1994-01-05 | Gambro Dialysatoren | Process for drying porous ultrafilter filtration membranes |
CA2149418C (en) | 1992-11-16 | 2002-01-01 | Anders Althin | High flux hollow fiber membrane |
US5336644A (en) * | 1993-07-09 | 1994-08-09 | Johnson Matthey Inc. | Sealing glass compositions |
NL9400013A (en) * | 1994-01-06 | 1995-08-01 | Akzo Nobel Nv | Material for extracting metal ions from an aqueous solution. |
JP2792556B2 (en) * | 1994-12-16 | 1998-09-03 | 東洋紡績株式会社 | Blood purification module, blood purification membrane and method for producing the same |
US5906742A (en) | 1995-07-05 | 1999-05-25 | Usf Filtration And Separations Group Inc. | Microfiltration membranes having high pore density and mixed isotropic and anisotropic structure |
US6026968A (en) | 1996-05-13 | 2000-02-22 | Nitto Denko Corporation | Reverse osmosis composite membrane |
US5983916A (en) * | 1996-12-31 | 1999-11-16 | Bp Amoco Corporation | Upgrade of below grade fill to at grade fill |
US6146747A (en) * | 1997-01-22 | 2000-11-14 | Usf Filtration And Separations Group Inc. | Highly porous polyvinylidene difluoride membranes |
US6218441B1 (en) * | 1997-09-18 | 2001-04-17 | Timothy B. Meluch | Melt-spun polysulfone semipermeable membranes and methods for making the same |
-
2002
- 2002-12-20 US US10/327,564 patent/US7144505B2/en not_active Expired - Fee Related
-
2003
- 2003-12-18 BR BR0317533-2A patent/BR0317533A/en not_active IP Right Cessation
- 2003-12-18 WO PCT/US2003/040499 patent/WO2004058385A1/en active Application Filing
- 2003-12-18 MX MXPA05006768A patent/MXPA05006768A/en unknown
- 2003-12-18 CA CA002511116A patent/CA2511116A1/en not_active Abandoned
- 2003-12-18 EP EP03814186A patent/EP1572331A1/en not_active Withdrawn
- 2003-12-18 CN CNA2003801070548A patent/CN1729044A/en active Pending
- 2003-12-18 AU AU2003301102A patent/AU2003301102A1/en not_active Abandoned
- 2003-12-18 JP JP2004563792A patent/JP2006511330A/en active Pending
- 2003-12-18 KR KR1020057011649A patent/KR20050086929A/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5762798A (en) * | 1991-04-12 | 1998-06-09 | Minntech Corporation | Hollow fiber membranes and method of manufacture |
EP0568045A1 (en) * | 1992-04-29 | 1993-11-03 | Kuraray Co., Ltd. | Polysulfone-based hollow fiber membrane and process for manufacturing the same |
EP0764461A1 (en) * | 1994-06-07 | 1997-03-26 | Mitsubishi Rayon Co., Ltd. | Porous polysulfone membrane and process for producing the same |
EP0716859A2 (en) * | 1994-12-16 | 1996-06-19 | TOYO BOSEKI KABUSHIKI KAISHA Trading under the name of Toyobo Co., Ltd. | Module for blood purification blood purification, membrane and its production |
EP0750938A1 (en) * | 1995-06-30 | 1997-01-02 | Toray Industries, Inc. | Polysulfone hollow fiber semipermeable membrane |
WO1998029478A1 (en) * | 1996-12-31 | 1998-07-09 | Althin Medical, Inc. | Melt-spun polysulfone semipermeable membranes and methods for making the same |
DE19817364C1 (en) * | 1998-04-18 | 1999-07-08 | Fresenius Medical Care De Gmbh | Hydrophilic asymmetric membrane used in ultrafiltration and reverse osmosis |
Non-Patent Citations (2)
Title |
---|
CABASSO I ET AL: "POLYSULFONE HOLLOW FIBERS. I. SPINNING AND PROPERTIES", JOURNAL OF APPLIED POLYMER SCIENCE, JOHN WILEY AND SONS INC. NEW YORK, US, vol. 20, 1976, pages 2377 - 2394, XP002064055, ISSN: 0021-8995 * |
CABASSO I ET AL: "POLYSULFONE HOLLOW FIBERS. II. MORPHOLOGY", JOURNAL OF APPLIED POLYMER SCIENCE, JOHN WILEY AND SONS INC. NEW YORK, US, vol. 21, 1977, pages 165 - 180, XP002064054, ISSN: 0021-8995 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1790364A1 (en) * | 2004-08-06 | 2007-05-30 | Asahi Kasei Medical Co., Ltd. | Polysulfone hemodialyzer |
EP1790364A4 (en) * | 2004-08-06 | 2010-04-07 | Asahi Kasei Kuraray Medical Co | Polysulfone hemodialyzer |
US8828225B2 (en) | 2004-08-06 | 2014-09-09 | Asahi Kasei Medical Co., Ltd. | Polysulfone hemodialyzer |
EP2277572A1 (en) * | 2009-07-22 | 2011-01-26 | Bellco S.r.l. | Dialysis machine with regeneration system |
ITBO20090473A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | DIALYSIS MACHINE WITH REGENERATIVE SYSTEM |
ITBO20090474A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | EMOFILTRATION MACHINE WITH REGENERATIVE SYSTEM |
ITBO20090471A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | ARTIFICIAL KIDNEY WEARABLE WITH REGENERATIVE SYSTEM |
EP2281591A1 (en) * | 2009-07-22 | 2011-02-09 | Bellco S.r.l. | Wearable artificial kidney with regeneration system |
ITBO20090472A1 (en) * | 2009-07-22 | 2011-01-23 | Bellco S R L Con Unico Socio | ARTIFICIAL KIDNEY WEARABLE WITH REGENERATIVE SYSTEM |
EP2365022A1 (en) | 2010-03-11 | 2011-09-14 | Gambro Lundia AB | Graft copolymers |
WO2011110600A1 (en) | 2010-03-11 | 2011-09-15 | Gambro Lundia Ab | Graft copolymers |
US8748538B2 (en) | 2010-03-11 | 2014-06-10 | Gambro Lundia Ab | Graft copolymers |
WO2013034611A1 (en) * | 2011-09-08 | 2013-03-14 | Gambro Lundia Ab | Hollow fiber membrane |
Also Published As
Publication number | Publication date |
---|---|
US7144505B2 (en) | 2006-12-05 |
CN1729044A (en) | 2006-02-01 |
KR20050086929A (en) | 2005-08-30 |
AU2003301102A1 (en) | 2004-07-22 |
EP1572331A1 (en) | 2005-09-14 |
JP2006511330A (en) | 2006-04-06 |
WO2004058385A9 (en) | 2004-11-25 |
MXPA05006768A (en) | 2005-09-08 |
BR0317533A (en) | 2005-11-22 |
CA2511116A1 (en) | 2004-07-15 |
US20040026315A1 (en) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7144505B2 (en) | Melt-spun polysulfone semipermeable membranes and methods for making the same | |
US6881337B2 (en) | Melt-spun polysulfone semipermeable membranes and methods for making the same | |
EP0568045B1 (en) | Polysulfone-based hollow fiber membrane and process for manufacturing the same | |
AU736217B2 (en) | Melt-spun polysulfone semipermeable membranes and methods for making the same | |
JP4656839B2 (en) | Halar film | |
EP2567750B1 (en) | Hollow fiber membrane | |
AU748844B2 (en) | Integrally asymmetrical polyolefin membrane | |
US6375876B1 (en) | Method for producing an integrally asymmetrical polyolefin membrane | |
MXPA99006130A (en) | Melt-spun polysulfone semipermeable membranes and methods for making the same | |
IE50102B1 (en) | Polycarbonate/polyether copolymer membrane,a process for its preparation and use thereof | |
AU672856B2 (en) | High flux hollow fiber membrane | |
JPH09323031A (en) | Polysulfonic permselective hollow-fiber membrane | |
JP2020533166A (en) | Microporous membrane and its manufacturing method | |
JP2000350926A (en) | Polysulfone hollow fiber membrane of selective permeablility | |
TW416973B (en) | Melt-spun polysulfone semipermeable membranes and compositions and methods for the preparation thereof | |
CA3216470A1 (en) | Polymeric membrane and methods for the production of same | |
JPS63224702A (en) | Polypropylene porous membrane and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1/5-5/5, DRAWINGS, REPLACED BY NEW PAGES 1/7-7/7 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003301102 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2502/DELNP/2005 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004563792 Country of ref document: JP Ref document number: 05059504 Country of ref document: CO Ref document number: 2511116 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038A70548 Country of ref document: CN Ref document number: 1020057011649 Country of ref document: KR Ref document number: PA/a/2005/006768 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003814186 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057011649 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003814186 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0317533 Country of ref document: BR |